I.R. emailI spoke with IR about all this Dilution basically if you want Agraflora here that's how it has to be until revenue comes in. Furthermore previous LOI's are no longer happening it's a whole new ballgame. Except the hemp biomass of SGSC should see revenue in Q3 from that. Asia deal is also in limbo. Also they will focus on their 4 core assets Delta, SGSC, EIC, Farmako Delta: will have deals set up before harvest. EIC: (Edibles) supply deals are underway should hear news soon also they should begin the minute they receive a license. Farmako: is working on more supply contracts, should hear more soon. End of 2020 all these should be generating revenue so 2021 will be a full year or revenue where they will re-evaluate other assets for use or sale.